This week Cuba says one of the COVID-19 vaccines the country is developing — called Abdala — is 92% effective after its three doses. It says another homegrown vaccine — Soberana 2 — is 62% effective after two of its three doses.
That seems to be a promising breakthrough for the communist island’s biopharma industry. Cuban President Miguel Díaz-Canel tweeted that his country’s Finlay Institute and Center for Genetic Engineering and Biotechnology “have risen above all the obstacles and given us two very effective vaccines.”
And not a moment too soon. Largely because its cash-strapped economy is in worse tatters than usual thanks to the pandemic, the communist island has not sought vaccines elsewhere — not even from the international COVAX project for poorer countries.
The trial domestic doses it’s administered so far have fully vaccinated less than a tenth of the population — and Cuba is experiencing one of its worst surges of COVID cases.
Several other Latin American countries have said they’re interested in importing Cuba’s vaccines. Cuba’s state-run biopharmaceutical sector is respected internationally for its vaccine production.
Copyright 2021 WLRN 91.3 FM. To see more, visit WLRN 91.3 FM.
